Acanthosis nigricans significantly impacts individuals with skin of color. No United States Food and Drug Administration (FDA)-approved therapy exists for acanthosis nigricans. This review evaluates visual scoring tools for assessing acanthosis nigricans severity, focusing on their utility in monitoring therapy response in clinical trials. Our analysis included five visual scoring tools and revealed that the Acanthosis Nigricans Scoring Chart is the most effective tool for monitoring acanthosis nigricans severity in response to therapy, while the Acanthosis Nigricans Area and Severity Index also remains a strong option for split-neck trials. Future tools should match severity scores with detailed descriptions and images. The inclusion of lesion size in future assessment tools requires careful consideration due to variable reliability among evaluators. This study highlights the need for a universally accepted acanthosis nigricans severity assessment tool. Advancing such methods is crucial to developing effective treatments and addressing healthcare disparities, particularly for individuals with skin of color. J Drugs Dermatol. 2025;24(2):156-161. doi:10.36849/JDD.8168R1.

Download full-text PDF

Source
http://dx.doi.org/10.36849/JDD.8168DOI Listing

Publication Analysis

Top Keywords

acanthosis nigricans
32
nigricans severity
12
assessment tools
8
acanthosis
8
nigricans
8
individuals skin
8
skin color
8
visual scoring
8
scoring tools
8
tools
5

Similar Publications

Novel estrogen receptor-α gene inactivating missense variant in a woman: Therapeutic challenge and long-term follow-up data.

Bone

March 2025

Centre de référence des maladies héréditaires du métabolisme, Hôpital d'enfants, Centre Hospitalier universitaire of Nancy and Faculty of Medicine, Midwifery and Health Professions, Université de Lorraine, F- 54000 Nancy, France; Centre Universitaire d'Enseignement par Simulation - CUESim, Virtual Hospital of Lorraine, Faculty of Medicine, Midwifery and Health Professions, Université de Lorraine, Nancy F- 54000, France; Centre de référence des maladies héréditaires du métabolisme, Hôpital d'enfants, rue Morvan, CHRU de Nancy, F- 54000 Nancy, France; Université de Lorraine, Inserm, DCAC, Nancy, France. Electronic address:

Background: Rare mutations of the ESR1 gene, encoding the estrogen receptor alpha (ERα), have been shown to cause estrogen resistance in humans. Phenotypic features include impaired maturation of epiphyseal cartilage, osteoporosis, and infertility. Clinical phenotype is not well described and the available data reflect inconsistency.

View Article and Find Full Text PDF

Acne is a pathology of the pilosebaceous unit. It is characterized by a highly complex etiopathology which includes inflammation, hyperkeratinization, increased sebum production, colonization of , hyperandrogenemia, and hyperinsulinemia. This condition, together with hirsutism, androgenic alopecia, and acanthosis nigricans, are highly prevalent cutaneous manifestations of the polycystic ovary syndrome (PCOS).

View Article and Find Full Text PDF

Background: Acanthosis nigricans (AN) is a common finding often associated with hyperinsulinemia and childhood obesity. There has been a lack of studies evaluating the association of AN with underlying cardio-metabolic risk factors in children and adolescents. Our objective was to study the association between AN and cardio-metabolic risk factors in children with overweight/obesity.

View Article and Find Full Text PDF

Objective: To evaluate the prevalence of prediabetes (PD), undiagnosed type 2 diabetes (T2D), metabolic syndrome (MetS), and insulin resistance (IR) as well as related risk factors in Mexican population from Guanajuato, Mexico.

Materials And Methods: We performed a cross-sectional study in the Mexican population from León, Guanajuato, Mexico. A clinical and metabolic evaluation was performed with an oral glucose test (OGTT); PD, undiagnosed T2D, MetS, and IR were identified according to international guidelines.

View Article and Find Full Text PDF

Paraneoplastic Dermatoses: A Clue for Underlying Malignancies.

J Clin Med

February 2025

Unit of Dermatology, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.

Paraneoplastic dermatoses (PDs) belong to a group of rare and polymorphous dermatoses, and they can often be the first sign of underlying malignancies. Therefore, dermatologists should be able to identify skin features to identify earlier underlying neoplasms. Indeed, lack of familiarity with cutaneous clues of internal malignancies can lead to a delay in the diagnosis and an impairment of the prognosis of the patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!